SCHEMBL19157167

SCHEMBL19157167

Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N(C)CCO)c2)cc1C

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.54
▸ RAB9A P51151 5/20 0.54
▸ NPC1 O15118 4/20 0.52
▸ KMT2A Q03164 6/20 0.52
▸ MEN1 O00255 5/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ MAPT P10636 4/20 0.51
▸ TSHR P16473 2/20 0.51
▸ SIRT2 Q8IXJ6 2/20 0.51
▸ HTT P42858 1/20 0.51
▸ GAA P10253 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ FKBP5 Q13451 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15276897 0.90 HTR2B (0.53) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL19157362 0.90 LMNA (0.54) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL15276891 0.88 LMNA (0.70) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL15276893 0.85 SIRT2 (0.60) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL15276793 0.84 SIRT2 (0.54) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL15276892 0.84 MAPT (0.56) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL20083990 0.84 LMNA (0.49) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL15276894 0.83 MEN1 (0.55) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL15276935 0.83 ALDH1A1 (0.50) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL15276896 0.83 LMNA (0.55) LMNARAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
EP-2794565-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2017-07-26 — — EP disclosed
Send feedback